Source link : https://newshealth.biz/health-news/in-pancreatic-cancer-does-new-paxg-beat-out-mfolfirinox/
CHICAGO — For patients with pancreatic resectable stage I-Ill pancreatic ductal adenocarcinoma (PDAC), neoadjuvant chemotherapy can help improve overall survival compared with upfront surgery. But what chemotherapy regimen provides the best survival outcomes? Findings from the phase 3 CASSANDRA PACT-21 trial, presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting, revealed that […]
The post In Pancreatic Cancer, Does New PAXG Beat Out mFOLFIRINOX? first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-01 20:04:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8